Quality of attendee. LSX events focus almost exclusively on 3 main profiles – Bio/Med/Health tech CEOs, investors, large pharma/medtech. That means our delegation is extremely focussed, extremely relevant and perfectly matched for partnering and investment. 


Quantity of attendee. LSX events occupy that sweet spot between smaller-scale conferences and large-scale exhibitions/trade shows. Our events are intimate enough to provide quality attendees in an accessible way (flagship events bring 400-2000 attendees) but also have enough critical mass to cover a wide range of geographies and all stages of development.


Qualification of attendee. All corporates, investor and pharma/medtech attendees are qualified during the registration process (if not before) to ascertain their stage of development, strategic goals, therapeutic preferences, and fundraising/allocation targets. This provides absolute clarity on the issues that matter most to our attendees and allows delegates and partners to identify and target the most qualified prospects through our highly sophisticated 1-2-1 partnering system.


Superior experience. LSX events are held at the highest-spec conference venues with significant attention to detail on a quality of experience for our attendees. That means unique and interesting content, superior hospitality and first-class staff on-site.


We’re not just about events! LSX is a year-round community of C-level life science execs. We see events as the culmination of our work, not the only thing we do. Because we engage with our network 365 days a year through content and regular meet-ups, we are seen as a valuable part of the industry, not a service provider to it. This means we have longer-held, deeper relationships with our clients than our competitors do. When we run events, we do so with the trust and support of a network that is regularly engaged with us.